PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [7]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2977978

  Goon P, Sauzet O, Schuermann M, et al. Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines. 2023;8(1): 49.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [6]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186

  Shao S, Scholtz L-U, Gendreizig S, et al. Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes. BMC Cancer. 2023;23(1): 47.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [5]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718

  Oppel F, Shao S, Gendreizig S, et al. Head and neck cancer cells can differentiate and resemble their tissue of origin. In: Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA. Cancer Research. Vol 82. American Association for Cancer Research (AACR); 2022: 111-111.

  PUB | DOI | WoS
   
• [4]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2967816

  Gendreizig S, Neumann JM, Loganathan L, et al. P35 Spatial proteomics and metabolomics investigations in head & neck cancers. Oral Oncology. 2022;134: 106164.

  PUB | DOI | WoS
   
• [3]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817

  Oppel F, Gendreizig S, Kühnel P, et al. P28 Head and neck cancer cells differentiate resembling their tissue of origin. In: Amsterdam University Medical Centers, ed. Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management. Oral Oncology. Vol 134. Elsevier ; 2022.

  PUB | DOI | WoS
   
• [2]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703

  Oppel F, Shao S, Gendreizig S, et al. p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition. Molecular Cancer Therapeutics. 2022.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [1]
  

  2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2951607

  Oppel F, Görner M, Sudhoff H. The Potential of Tumor Debulking to Support Molecular Targeted Therapies. Frontiers in Oncology. 2020;10: 801.

  PUB | DOI | WoS | PubMed | Europe PMC